News | May 08, 2015

NIH Summit Delivers Recommendations to Transform Alzheimer’s Disease Research

Recommendations call for greater collaboration to develop new tools and focus research

NIH, Alzheimer's, recommendations, Research Summit 2015

May 8, 2015 — The National Institutes of Health (NIH) released recommendations that provide a framework for a bold and transformative Alzheimer’s disease research agenda. Developed at the recent Alzheimer’s Disease Research Summit 2015: Path to Treatment and Prevention, the recommendations provide the wider Alzheimer’s research community with a strategy for speeding the development of effective interventions for Alzheimer’s and related dementias. These recommendations call for a change in how the academic, biopharmaceutical and government sectors participating in Alzheimer’s research and therapy generate, share and use knowledge to propel the development of critically needed therapies.

In the recent past, Alzheimer’s research has rapidly expanded with the introduction of U.S. Food and Drug Administration (FDA)-cleared nuclear imaging agents to visualize beta-amyloid plaques in the brain. Prior to these agents, the only definitive confirmation of Alzheimer’s was a post-mortem brain biopsy.

“Alzheimer’s research is entering a new era in which creative approaches for detecting, measuring and analyzing a wide range of biomedical data sets are leading to new insights about the causes and course of the disease,” said NIH Director Francis S. Collins, M.D., Ph.D. “In these times of significant fiscal constraints, we need to work smarter, faster and more collaboratively. These recommendations underscore the importance of data sharing and multidisciplinary partnerships to a research community that looks to the NIH for guidance on the way forward.”

More than 60 leading Alzheimer’s and chronic disease experts from academia, industry, nonprofit organizations and advocacy groups joined to develop the research recommendations. Convened by the National Institute on Aging (NIA) at NIH and the U.S. Department of Health and Human Services, with support from the Foundation for NIH, the Feb. 9–10, 2015, meeting drew 500 participants onsite, with another 500 participating via videocast.

The recommendations, which are to be considered by the National Advisory Council on Aging at its meeting on May 12 and 13, outline new scientific approaches to address critical knowledge gaps and propose ways to harness emerging technologies to accelerate treatments for people at all stages of the disease. They also identify infrastructure and partnerships necessary to successfully implement the new research agenda and strategies to empower patients and engage citizens.

Overarching Alzheimer’s disease research themes include

  • Understand all aspects of healthy brain aging and cognitive resilience to inform strategies for Alzheimer’s disease prevention;
  • Expand integrative, data-driven research approaches such as systems biology and systems pharmacology;
  • Develop computational tools and infrastructure in order to enable storage, integration and analysis of large-scale biological and other patient-relevant data;
  • Leverage the use of wearable sensors and other mobile health technologies to inform discovery science as well as research on Alzheimer’s disease care;
  • Support and enable Open Science in basic, translational and clinical research;
  • Change the academic, publishing and funding incentives to promote collaborative, transparent and reproducible research;
  • Invest in the development of a new translational and data science workforce; and
  • Engage citizens, caregivers and patients as equal partners in Alzheimer’s disease research.

 

“Determining the best path for progress in Alzheimer’s disease research has been as challenging and complicated as the disorder itself,” said NIA Director Richard J. Hodes, M.D. “These recommendations support a research framework that empowers all stakeholders — including those with the disease or at risk for developing it — to engage in the vital effort to find treatments.”

The recommendations will be used to update and expand specific milestones for achieving the prime research goal of the National Plan to Address Alzheimer’s Disease — that of finding effective therapies to treat or prevent Alzheimer’s disease and related dementias by 2025.

For more information: www.nih.gov

Related Content

Aidoc Receives FDA Clearance for AI Detection of Acute Intracranial Hemorrhage
Technology | Clinical Decision Support | August 08, 2018
Aidoc announced that it was granted U.S. Food and Drug Administration (FDA) clearance for the first product of its...
CT Decision Instrument Reliably Guides Pediatric Blunt Trauma imaging Decisions

This is a four-site prospective observational cohort. Image courtesy of Kirsty Challen, B.Sc., MBCHB, MRES, Ph.D., Lancashire Teaching Hospitals, United Kingdom.

News | Clinical Decision Support | July 18, 2018
A new study finds The Pediatric NEXUS Head Computed Tomography (CT) Decision Instrument (DI) reliably identifies blunt...
Artificial Intelligence Provides Faster, Clearer MRI Scans

A new artificial-intelligence-based approach to image reconstruction, called AUTOMAP, yields higher quality images from less data, reducing radiation doses for CT and PET and shortening scan times for MRI. Shown here are MR images reconstructed from the same data with conventional approaches, at left, and AUTOMAP, at right. Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital

News | Artificial Intelligence | July 17, 2018
A research team with funding from the National Institute for Biomedical Imaging and Bioengineering (NIBIB) has...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
Neural Analytics Inc. Receives CE Mark for Robotic Ultrasound System
Technology | Ultrasound Imaging | July 03, 2018
Medical robotics company Neural Analytics Inc. announced that it received CE Mark for its NeuralBot System, a robotic...
Dictum Health Launches Advanced Telestroke Module for Virtual Exam Room Platform
Technology | Teleradiology | June 28, 2018
Dictum Health Inc., creators of the Virtual Exam Room (VER) telehealth technology, announced the release of their Care...
Smoking and Diabetes Linked to Brain Calcifications
News | Neuro Imaging | June 26, 2018
People who smoke or have diabetes may be at increased risk of calcifications in a region of the brain crucial to memory...
Children with Kidney Disease Show Blood Flow Changes in Brain
News | Neuro Imaging | June 25, 2018
Blood flow changes in the brains of children, adolescents and young adults with chronic kidney disease may explain why...
American Society of Neuroradiology Honors Peter Chang with Cornelius G. Dyke Memorial Award
News | Neuro Imaging | June 13, 2018
Peter Chang, M.D., current neuroradiology fellow at UCSF and recently recruited co-director of the UCI Center for...
Overlay Init